APVO icon

Aptevo Therapeutics

hedge funds and large institutions have $29.6M invested in Aptevo Therapeutics in 2017 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1 -$4.4M
2 -$2.05M
3 -$1.61M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.5M
5
BlackRock
BlackRock
New York
-$1.2M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$112K
27
$101K
28
$92K
29
$87K
30
$86K
31
$81K
32
$76K
33
$75K
34
$66K
35
$58K
36
$56K
37
$53K
38
$49K
39
$47K
40
$45K
41
$24K
42
$15K
43
$10K
44
$8K
45
$6K
46
$6K
47
$6K
48
$5K
49
$2K
50
$1K